Oxidative stress present in the blood from obese patients modifies the structure and function of insulin.
Obesity and its associated disorders constitute a growing epidemic across the world. Numerous studies have demonstrated the presence of systemic oxidative stress in patients with obesity. In this study, we show the effects of oxidative stress present in the blood from obese patients on recombinant human insulin. Insulin was incubated with whole blood (WB) from overweight subjects (OW), obese 1 patients (O1), or normal weight volunteers (NW) (n=16 for each group). Whole blood from OW and O1, unlike WB from NW, increased the carbonyl content of insulin; however, only whole blood from O1 patients increased the amount of formazan present in the hormone. Interestingly, the incubation of insulin with WB from O1 provoked a decrease in the hypoglycemic activity of the hormone (18%), an effect due to insulin polymerization. In addition, we showed that the formation of the insulin polymer generated the formation of new epitopes and the development of a new immunogenicity. These observations show that oxidative stress present in the WB of O1 patients can result in abolition of the biological activity of insulin and contribute to the development of an immune response to the hormone.
Postgraduate Studies and Research Section, School of Medicine National Polytechnique Institute, Mexico Distrito Federal, Mexico.
I M
IM
Olivares-Corichi
M J Rincon
MJ
Viquez
L
L
Gutierrez-Lopez
G M
GM
Ceballos-Reyes
J R
JR
Garcia-Sanchez
D000328:Adult; D000818:Animals; D000937:Antigen-Antibody Reactions; D015415:Biomarkers / Q000097:blood; D015992:Body Mass Index; D005260:Female; D005562:Formazans / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000737:chemistry* / Q000302:isolation & purification / Q000494:pharmacology; D007333:Insulin Resistance; D061386:Insulin, Regular, Human / Q000737:chemistry* / Q000302:isolation & purification / Q000494:pharmacology; D051379:Mice; D009765:Obesity / Q000097:blood* / Q000276:immunology; D050177:Overweight / Q000097:blood / Q000276:immunology; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D058105:Polymerization; D050050:Protein Carbonylation; D011994:Recombinant Proteins / Q000737:chemistry; D055815:Young Adult
D015415:Biomarkers; D005562:Formazans; D007004:Hypoglycemic Agents; D061386:Insulin, Regular, Human; D011994:Recombinant Proteins